— Know what they know.
Not Investment Advice
Also trades as: ATH.AX (ASX) · $vol 0M · PRNAF (OTC) · $vol 0M

ATHE NASDAQ

Alterity Therapeutics Limited
1W: -9.3% 1M: -26.3% 3M: -43.5% YTD: +5.4% 1Y: -15.7% 3Y: +26.6% 5Y: -74.4%
$3.45
-0.04 (-1.15%)
 
Weekly Expected Move ±10.9%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 30 · $58.4M mcap · 12M float · 0.323% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$46M -0.0% ▼
5Y CAGR: +6.5%
Total Liabilities
$3M -9.1% ▼
5Y CAGR: +1.1%
Shareholders Equity
$43M +0.8% ▲
5Y CAGR: +7.0%
Cash & Investments
$37M -8.2% ▼
5Y CAGR: +5.8%
Total Debt
$193K +24.5% ▲
5Y CAGR: +24.1%
Net Debt
-$37M -12.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$35M$16M$13M$33M$37M
Short-Term Investments$0$0$0$8M$0
Cash & ST Investments$35M$16M$13M$41M$37M
Net Receivables$5M$9M$4M$4M$8M
Inventory$0$0$0$0$0
Other Current Assets$66K$57K$41K$42K$43K
Total Current Assets$41M$27M$19M$46M$46M
Property, Plant & Equip.$219K$269K$187K$155K$191K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$219K$269K$187K$155K$191K
Total Assets$41M$27M$19M$46M$46M
— Liabilities —
Accounts Payable$3M$2M$581K$538K$1M
Short-Term Debt$0$0$0$0$55K
Deferred Revenue-$58K-$107K$0$0$0
Other Current Liabilities$3M$169K$4M$876K$891K
Total Current Liabilities$6M$4M$5M$4M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$14K$20K$0$0$0
Total Non-Current Liabilities$74K$123K$52K$89K$138K
Total Liabilities$6M$5M$5M$4M$3M
— Equity —
Common Stock$214M$214M$223M$263M$283M
Retained Earnings-$182M-$195M-$214M-$226M-$246M
Accumulated OCI$4M$4M$5M$5M$6M
Total Stockholders Equity$35M$23M$14M$42M$43M
Total Liabilities & Equity$41M$27M$19M$46M$46M
— Key Metrics —
Total Debt$117K$210K$159K$155K$193K
Net Debt-$35M-$16M-$12M-$33M-$37M
Total Investments$0$0$0$8M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms